Monday, April 14 14:36:40
Ethicon Biosurgery Ireland has announced the creation of around 270 jobs in Limerick over the next five years.
Part of the Johnson and Johnson Family of Companies, Ethicon Biosurgery is planning an E80m manufacturing facility development at the National Technology Park at Plassey, Limerick.
The 60,000 square foot facility is expected to be completed by next year and an additional 150 temporary jobs will be created during construction. Recruitment to fill the approximately 270 new Ethicon jobs has already begun.
The new Limerick facility will manufacture EVARREST Sealant Matrix, a novel product that rapidly and reliably aids in stopping bleeding during surgery.
The investment is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.
Minister Bruton, who met senior Johnson and Johnson executives and discussed this project as part of a recent IDA investment mission to the US, described today's announcement as "brilliant news".
"Manufacturing is a central pillar of the Government's Action Plan for Jobs, and we have put in place a series of measures to help reverse the decline in employment in this area in the past," the Minister said.
"This is a model of what we are trying to achieve with our plan - a great global company investing E80 million in a manufacturing plant in Limerick, creating large numbers of permanent jobs as well as construction jobs, with huge knock-on benefits for the surrounding areas. I know Ethicon Biosurgery and IDA have worked hard to get to this point, and I wish the company every success with this project".
Speaking at today's announcement, Dan Wildman, Worldwide President, Ethicon Biosurgery, said: "The decision to manufacture EVARREST Sealant Matrix in Ireland was due to the unique clustering of medical device manufacturing, automation and biomanufacturing skill sets across the Johnson and Johnson companies already operating in Ireland."
Speaking of today's announcement, Finance Minister Michael Noonan said: "I am delighted that Ethicon Biosurgery has chosen Limerick as the location for their new state-of-the-art manufacturing facility which will create 270 number high-calibre jobs," said Minister Noonan.
"The IDA is doing an excellent job in attracting jobs and investment to Limerick and with each new investment, the attractiveness of Limerick as a world class hub for life science and high tech companies is growing. I had the pleasure of meeting senior Johnson and Johnson executives with the IDA in New York in January to discuss this exciting project and I would like to wish the management and team here every success."
Barry O'Leary, CEO, IDA Ireland described the Ethicon Biosurgery investment as "hugely significant for the Mid West region as a whole".